BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19919994)

  • 1. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling.
    Seki K; Sanada S; Kudinova AY; Steinhauser ML; Handa V; Gannon J; Lee RT
    Circ Heart Fail; 2009 Nov; 2(6):684-91. PubMed ID: 19919994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
    Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
    J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 Directly Activates Myocardial STAT3 (Signal Transducer and Activator of Transcription-3) Signaling Pathway and Prevents Myocardial Ischemia Reperfusion Injury.
    Takahashi J; Yamamoto M; Yasukawa H; Nohara S; Nagata T; Shimozono K; Yanai T; Sasaki T; Okabe K; Shibata T; Mawatari K; Kakuma T; Aoki H; Fukumoto Y
    J Am Heart Assoc; 2020 Apr; 9(8):e014814. PubMed ID: 32301368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
    Qian W; Zhao C; Li D; Dai R
    Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
    Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
    Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
    JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G; Arnoletti E; Bassino E; Penna C; Perrelli MG; Ghé C; Muccioli G
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H470-81. PubMed ID: 20525876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury.
    Chen C; Feng Y; Zou L; Wang L; Chen HH; Cai JY; Xu JM; Sosnovik DE; Chao W
    J Am Heart Assoc; 2014 Jan; 3(1):e000683. PubMed ID: 24390148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction.
    Asensio-Lopez MC; Lax A; Fernandez Del Palacio MJ; Sassi Y; Hajjar RJ; Januzzi JL; Bayes-Genis A; Pascual-Figal DA
    J Mol Cell Cardiol; 2019 May; 130():216-233. PubMed ID: 30998979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of beta-blocker therapy on modulation of interleukin-33/ST2 signaling during ventricular remodeling after acute myocardial infarction.
    Xia J; Qu Y; Yin C; Xu D
    Cardiol J; 2017; 24(2):188-194. PubMed ID: 27748502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
    Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
    Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
    J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.
    Demyanets S; Kaun C; Pentz R; Krychtiuk KA; Rauscher S; Pfaffenberger S; Zuckermann A; Aliabadi A; Gröger M; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2013 Jul; 60():16-26. PubMed ID: 23567618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.
    Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F
    PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.